DBG
De Burlo Group Portfolio holdings
AUM
$759M
This Quarter Return
+23.64%
1 Year Return
+24.77%
3 Year Return
+146.35%
5 Year Return
+326.03%
10 Year Return
+1,922.48%
AUM
$495M
AUM Growth
+$495M
(+11%)
Cap. Flow
+$66.2M
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
32.63%
Holding
110
New
20
Increased
26
Reduced
43
Closed
17
Top Buys
| 1 |
Palo Alto Networks
PANW
|
$18.5M |
| 2 |
CyberArk
CYBR
|
$11.3M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
$11M |
| 4 |
Edwards Lifesciences
EW
|
$10.9M |
| 5 |
Veeva Systems
VEEV
|
$9.64M |
Top Sells
| 1 |
Church & Dwight Co
CHD
|
$13.5M |
| 2 |
Merck
MRK
|
$11.7M |
| 3 |
UnitedHealth
UNH
|
$10.8M |
| 4 |
Verizon
VZ
|
$9.81M |
| 5 |
Zoetis
ZTS
|
$9.02M |
Sector Composition
| 1 | Technology | 27.07% |
| 2 | Healthcare | 21.86% |
| 3 | Financials | 16.48% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Real Estate | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
51
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.24M | 0.45% |
16,560
-2,850
| -15% | -$385K |
|
52
Fortive
FTV
$16.2B
| $2.23M | 0.45% |
26,599
-5,888
| -18% | -$494K |
|
|
ABMD
53
DELISTED
Abiomed Inc
ABMD
| $2.13M | 0.43% |
7,450
-1,750
| -19% | -$500K |
|
|
54
UnitedHealth
UNH
$281B
| $2.13M | 0.43% |
8,600
-43,650
| -84% | -$10.8M |
|
|
55
Church & Dwight Co
CHD
$22.7B
| $2.12M | 0.43% |
29,800
-189,200
| -86% | -$13.5M |
|
56
Masimo
MASI
$7.59B
| $2.09M | 0.42% |
15,100
-4,200
| -22% | -$581K |
|
57
TJX Companies
TJX
$152B
| $2.01M | 0.4% |
37,700
-60,800
| -62% | -$3.24M |
|
58
Comfort Systems
FIX
$24.8B
| $2M | 0.4% |
+38,200
| New | +$2M |
|
59
Atmos Energy
ATO
$26.7B
| $1.99M | 0.4% |
19,300
-1,900
| -9% | -$196K |
|
60
Allison Transmission
ALSN
$7.3B
| $1.84M | 0.37% |
+41,000
| New | +$1.84M |
|
61
Netflix
NFLX
$513B
| $1.58M | 0.32% |
4,425
-955
| -18% | -$341K |
|
62
Henry Schein
HSIC
$8.44B
| $1.49M | 0.3% |
24,710
-7,900
| -24% | -$475K |
|
63
Norfolk Southern
NSC
$62.8B
| $1.3M | 0.26% |
+700
| New | +$1.3M |
|
64
Ingevity
NGVT
$2.13B
| $1.19M | 0.24% |
+11,300
| New | +$1.19M |
|
65
Bright Horizons
BFAM
$6.71B
| $1.16M | 0.23% |
9,100
-1,100
| -11% | -$140K |
|
66
Gilead Sciences
GILD
$140B
| $1.12M | 0.23% |
17,290
-7,400
| -30% | -$481K |
|
67
Neurocrine Biosciences
NBIX
$13.8B
| $1.11M | 0.22% |
12,650
-3,650
| -22% | -$321K |
|
68
Masco
MAS
$15.4B
| $1.03M | 0.21% |
26,200
-5,300
| -17% | -$208K |
|
69
General Mills
GIS
$26.4B
| $934K | 0.19% |
18,050
-2,950
| -14% | -$153K |
|
70
Cognex
CGNX
$7.38B
| $926K | 0.19% |
18,200
+500
| +3% | +$25.4K |
|
71
Reinsurance Group of America
RGA
$12.9B
| $838K | 0.17% |
5,900
-1,000
| -14% | -$142K |
|
72
Integra LifeSciences
IART
$1.18B
| $808K | 0.16% |
14,498
+2,544
| +21% | +$142K |
|
73
Magna International
MGA
$12.9B
| $699K | 0.14% |
14,350
-600
| -4% | -$29.2K |
|
74
Nike
NKE
$114B
| $657K | 0.13% |
7,800
-9,400
| -55% | -$792K |
|
75
American Water Works
AWK
$28B
| $620K | 0.13% |
5,950
+550
| +10% | +$57.3K |
|